Skip to main content
. 2019 Aug 1;19:204. doi: 10.1186/s12877-019-1215-y

Table 1.

Baseline characteristics in the whole sample and according to the care settings

General characteristics, % (N) Whole sample Acute care Rehabilitation care Nursing home pa
N = 1478 N = 382 N = 322 N = 774
Heart failure type
 Decompensated 21.4 (316) 51.2 (195) 16.6 (53) 8.79 (68) <.0001
 Stable 78.6 (1158) 48.8 (186) 83.4 (266) 91.2 (706)
Age (years), M (SD) 88.2 (5.2) 87.8 (4.9) 87.3 (5.2) 88.7 (5.3) <.0001
Women 68.9 (1014) 61.4 (234) 61.4 (197) 75.7 (583) <.0001
Weight (Kg), M (SD) 64.6 (15.4) 66.8 (16.7) 63.4 (15.4) 64.1 (14.7) 0.005
Systolic blood pressure (mmHg), M (SD) 126 (19) 126 (20) 124 (19) 127 (18) 0.04
Diastolic blood pressure (mmHg), M (SD) 68.9 (11.5) 68.7 (12.3) 66.9 (10.8) 69.9 (11.4) 0.0005
Orthostatic hypotension 18.5 (137) 15.5 (28) 16.7 (26) 20.6 (83) 0.26
Heart rate (beats per minute), M (SD) 74.0 (12.7) 76.3 (13.8) 74.9 (13.0) 72.4 (11.7) <.0001
Diabetes mellitus 22.1 (326) 23.0 (88) 25.2 (81) 20.3 (157) 0.18
Hypertension 77.6 (1144) 76.4 (291) 76.9 (594) 80.4 (259) 0.37
History of stroke 19.8 (293) 20.4 (78) 17.7 (57) 20.4 (158) 0.55
History of myocardial infarction 28.5 (421) 32.8 (125) 37.2 (119) 22.9 (177) <.0001
Peripheral arterial disease 20.0 (295) 20.2 (77) 19.6 (152) 20.6 (66) 0.93
Acute infection 44.1 (436) 46.9 (149) 42.6 (106) 43.0 (181) 0.49
Dementia 52.3 (772) 39.0 (149) 46.0 (148) 61.4 (475) <.0001
Depression 34.1 (503) 22.8 (87) 32.7 (105) 40.2 (311) <.0001
History of falls 32.5 (480) 33.0 (126) 44.1 (142) 27.4 (212) <.0001
COPD 24.6 (363) 24.9 (95) 22.4 (72) 25.3 (196) 0.58
Cancer 16.3 (241) 16.2 (62) 18.9 (61) 15.2 (118) 0.32
eGFR (mL/min), M (SD) 35.1 (16.3) 33.7 (15.7) 35.5 (16.2) 35.6 (17.5) 0.19
Hemoglobin (g/dL), M (SD) 11.8 (1.7) 11.6 (1.8) 11.5 (1.5) 12.1 (1.6) <.0001
Anemia 59.9 (864) 63.5 (240) 53.7 (400) 70.2 (224) <.0001
Albumin (g/L), M (SD) 32.7 (5.2) 32.1 (5.7) 31.6 (5.1) 33.8 (4.8) <.0001
Malnutrition (albumin < 35 g/l) 64.1 (754) 65.9 (220) 60.1 (336) 70.0 (198) 0.01
Brain natriuretic peptide (pg/mL), M (SD) 993 (1793) 1329 (2282) 1208 (1858) 622 (1160) 0.004
NTproBNP (pg/mL), M (SD) 5926 (9587) 8489 (12237) 7165 (9517) 3317 (6000) <.0001
LVEF %, M (SD) 52.9 (14.4) 51.3 (15.6) 50.0 (14.4) 55.7 (13.1) <.0001
LVEF level in 3 classes
 LVEF < 40% 15.6 (120) 18.8 (41) 22.1 (44) 9.92 (35)
 LVEF 40–49% 14.8 (114) 13.8 (30) 16.6 (33) 14.4 (51) 0.0009
 LVEF ≥50% 69.6 (536) 67.4 (147) 61.3 (122) 75.6 (267)
Atrial fibrillation 43.2 (614) 48.0 (181) 45.1 (142) 39.9 (291) 0.03
Antiplatelet drugs 44.4 (655) 43.0 (163) 46.6 (150) 44.2 (342) 0.63
Statins 21.4 (316) 23.9 (91) 27.4 (88) 17.7 (137) 0.0007
Anticoagulants 47.0 (694) 63.9 (244) 60.2 (194) 33.1 (256) <.0001
Total number of drugs, M (SD) 8.43 (3.29) 8.30 (3.43) 8.71 (3.40) 8.37 (3.17) 0.22
Age-adjusted Charlson score, M (SD) 8.49 (2.21) 8.48 (2.27) 8.42 (1.99) 8.66 (2.60) 0.25

% (N) percentage (number); M (SD) mean (standard deviation), eGFR estimated glomerular filtration rate calculated with Cockcroft formula, LVEF left ventricular ejection fraction, COPD chronic obstructive pulmonary disease

a ANOVA test or χ2